Author/Authors :
Manfrini، نويسنده , , Olivia and Pizzi، نويسنده , , Carmine and Morgagni، نويسنده , , GianLuigi and Fontana، نويسنده , , Fiorella and Bugiardini، نويسنده , , Raffaele، نويسنده ,
Abstract :
We studied the effect of pravastatin on coronary perfusion after percutaneous transluminal coronary angioplasty. An exercise test performed within 2 weeks after percutaneous transluminal coronary angioplasty induced reversible perfusion defects in 66% of patients taking pravastatin and 64% of those taking placebo. At follow-up, the exercise test still induced reversible perfusion defects in 3% of patients taking pravastatin and 29% of those taking placebo.
